Side-by-side comparison of AI visibility scores, market position, and capabilities
Commonwealth Fusion Systems (CFS) is building compact high-temperature superconducting fusion reactors, with SPARC demonstrating net energy gain targeted for 2025 and commercial reactors by early 2030s. HQ: Devens, MA.
Commonwealth Fusion Systems (CFS) is a fusion energy company spun out of MIT's Plasma Science and Fusion Center in 2018, commercializing decades of fusion research through a proprietary approach using high-temperature superconducting (HTS) magnets. CFS's strategy centers on making fusion magnets much stronger than previously possible: HTS magnets can achieve field strengths of 20+ Tesla (more than twice conventional magnet capability), which allows fusion reactors to be dramatically smaller and cheaper — potentially shrinking a fusion power plant from stadium-scale to building-scale. The company's first demonstration reactor, SPARC, is under construction in Devens, Massachusetts.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.